NO20024324L - Legemidler for diagnose av vevsreproduktiv aktivitet eller behandling av proliferative sykdommer - Google Patents

Legemidler for diagnose av vevsreproduktiv aktivitet eller behandling av proliferative sykdommer

Info

Publication number
NO20024324L
NO20024324L NO20024324A NO20024324A NO20024324L NO 20024324 L NO20024324 L NO 20024324L NO 20024324 A NO20024324 A NO 20024324A NO 20024324 A NO20024324 A NO 20024324A NO 20024324 L NO20024324 L NO 20024324L
Authority
NO
Norway
Prior art keywords
diagnosis
treatment
denotes
substituent
tissue
Prior art date
Application number
NO20024324A
Other languages
English (en)
Other versions
NO328812B1 (no
NO20024324D0 (no
Inventor
Jun Toyohara
Akio Hayashi
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20024324D0 publication Critical patent/NO20024324D0/no
Publication of NO20024324L publication Critical patent/NO20024324L/no
Publication of NO328812B1 publication Critical patent/NO328812B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20024324A 2001-01-23 2002-09-10 Middel for diagnose av vevsproliferasjonsaktivitet, nukleosidderivat og fremgangsmate for fremstilling av en radiomerket forbindelse NO328812B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001014954 2001-01-23
PCT/JP2002/000408 WO2002058740A1 (fr) 2001-01-23 2002-01-22 Medicaments destines au diagnostic de l'activite reproductrice tissulaire ou au traitement de maladies proliferatives

Publications (3)

Publication Number Publication Date
NO20024324D0 NO20024324D0 (no) 2002-09-10
NO20024324L true NO20024324L (no) 2002-11-07
NO328812B1 NO328812B1 (no) 2010-05-18

Family

ID=18881578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024324A NO328812B1 (no) 2001-01-23 2002-09-10 Middel for diagnose av vevsproliferasjonsaktivitet, nukleosidderivat og fremgangsmate for fremstilling av en radiomerket forbindelse

Country Status (14)

Country Link
US (2) US7045115B2 (no)
EP (1) EP1270017B1 (no)
JP (1) JP4210118B2 (no)
KR (1) KR100867729B1 (no)
CN (1) CN100400107C (no)
AT (1) ATE322912T1 (no)
AU (1) AU2002226690B2 (no)
CA (1) CA2402991C (no)
DE (1) DE60210538T2 (no)
HK (1) HK1059396A1 (no)
NO (1) NO328812B1 (no)
NZ (1) NZ520934A (no)
TW (1) TWI247609B (no)
WO (1) WO2002058740A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
WO2005026131A1 (en) * 2003-09-05 2005-03-24 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure and inhibitors of thymidine phosphorylases
WO2005027962A1 (en) * 2003-09-18 2005-03-31 Isis Pharmaceuticals, Inc. 4’-thionucleosides and oligomeric compounds
US7485283B2 (en) * 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
JP4841231B2 (ja) * 2005-11-07 2011-12-21 日本メジフィジックス株式会社 組織増殖能診断用薬剤
BRPI0710671B8 (pt) * 2006-04-07 2021-05-25 Univ Texas uso de um vetor de bacteriofágo viral adenoassociado (aavp) terapêutico para a fabricação de um medicamento para o tratamento e profilaxia de uma doença hiperproliferativa
US7928210B2 (en) 2007-03-01 2011-04-19 Siemens Medical Solutions Usa, Inc. Nucleoside based proliferation imaging markers
CN101730538B (zh) * 2007-04-10 2015-04-29 约翰·霍普金斯大学 与病毒相关肿瘤的成像和疗法
PT2257315T (pt) * 2008-02-29 2020-01-27 Lantheus Medical Imaging Inc Agentes de contraste para aplicações incluindo imagiologia de perfusão
GB0815831D0 (en) * 2008-09-01 2008-10-08 Imp Innovations Ltd Compounds
PT2419096T (pt) 2009-04-15 2020-02-19 Lantheus Medical Imaging Inc Estabilização de composições radiofarmacêuticas utilizando ácido ascórbico
PT2534136T (pt) 2010-02-08 2017-12-15 Lantheus Medical Imaging Inc Métodos para sintetizar agentes de imagiologia, e seus intermediários
WO2012048331A2 (en) * 2010-10-09 2012-04-12 Phynexus, Inc. Isolation of phosphoproteins, glycoproteins and fragments thereof
JP5794521B2 (ja) * 2011-03-29 2015-10-14 国立大学法人福井大学 アポトーシス誘導剤
AU2013241341B2 (en) 2012-03-28 2016-09-08 Fujifilm Corporation Salt of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
PT2883866T (pt) 2012-08-13 2019-04-05 Fujifilm Corp Intermediário para a síntese de 1-(2-desoxi-2-fluoro-4-tiobeta-d-arabinofuranosilo)citosina, intermediário para a síntese de tionucleósido e métodos para a produção destes intermediários
JP2014062054A (ja) * 2012-09-20 2014-04-10 Gyoseiin Genshino Iinkai Kakuno Kenkyusho よう素−１２３標記チミン類似物［１２３Ｉ］−ＩａｒａＵのプローブ
JP6351107B2 (ja) * 2014-02-18 2018-07-04 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
TWI678373B (zh) 2014-10-31 2019-12-01 日商富士軟片股份有限公司 硫代核苷衍生物或其鹽及醫藥組合物
AU2017319260B2 (en) 2016-08-31 2020-01-30 Fujifilm Corporation Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit
MX2018002611A (es) 2018-01-29 2019-07-30 Fujifilm Corp Agente antitumoral para cancer del tracto biliar y metodo para tratar cancer del tracto biliar.
CN113683648A (zh) * 2021-08-26 2021-11-23 上海皓鸿生物医药科技有限公司 一种2’-氟-2’-脱氧尿苷的合成方法及其中间体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides
US5077034A (en) * 1990-03-30 1991-12-31 The President And Fellows Of Harvard College Treatment of tumors with 5-radioiodo-2'-deoxyuridine
US5248771A (en) 1991-06-26 1993-09-28 Triumf Process for preparing no-carrier-added radiohalogenated vinyl nucleosides
GB9421223D0 (en) 1994-10-21 1994-12-07 Univ Alberta Tissue imaging in gene therapy
US5574148A (en) 1995-02-02 1996-11-12 President U Fellows Of Harvard College Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides
US5703056A (en) 1995-03-15 1997-12-30 Sloan-Kettering Institute For Cancer Research Non-invasive imaging of gene transfer
US5720935A (en) 1995-06-09 1998-02-24 President & Fellows Of Harvard College Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides from stannyl precursors
AU5774796A (en) 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin
US6331287B1 (en) 1995-08-23 2001-12-18 University Advanced Bio-Imaging Associates 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside
WO2001005439A1 (en) * 1999-07-14 2001-01-25 President And Fellows Of Harvard College Radiodetection and therapy of aberrant cell proliferation
KR200188038Y1 (ko) 2000-01-24 2000-07-15 이정진 전자파 피해가 감소되는 안테나 구조를 가진 휴대폰.

Also Published As

Publication number Publication date
ATE322912T1 (de) 2006-04-15
AU2002226690B2 (en) 2006-07-13
WO2002058740A1 (fr) 2002-08-01
US7045115B2 (en) 2006-05-16
HK1059396A1 (en) 2004-07-02
JPWO2002058740A1 (ja) 2004-05-27
EP1270017A1 (en) 2003-01-02
US20050129611A1 (en) 2005-06-16
CA2402991C (en) 2009-06-23
NZ520934A (en) 2004-12-24
EP1270017A4 (en) 2004-04-28
CN1455683A (zh) 2003-11-12
CN100400107C (zh) 2008-07-09
DE60210538T2 (de) 2006-10-05
JP4210118B2 (ja) 2009-01-14
NO328812B1 (no) 2010-05-18
TWI247609B (en) 2006-01-21
US7118731B2 (en) 2006-10-10
EP1270017B1 (en) 2006-04-12
KR100867729B1 (ko) 2008-11-10
KR20020084212A (ko) 2002-11-04
US20030124054A1 (en) 2003-07-03
CA2402991A1 (en) 2002-08-01
DE60210538D1 (de) 2006-05-24
NO20024324D0 (no) 2002-09-10

Similar Documents

Publication Publication Date Title
NO20024324D0 (no) Legemidler for diagnose av vevsreproduktiv aktivitet eller behandling av proliferative sykdommer
ID27531A (id) Penggunaan senyawa untuk peningkatan aktivitas piruvat dehidrogenase
RU2009143333A (ru) Производные аминодигидротиазина, замещенные циклической группой
NO20052914L (no) Terapeutiske forbindelser
NO933452D0 (no) Et terapeutisk middel for parkinson's sykdom
MY148937A (en) Medicaments with hm74a receptor activity
EA028673B1 (ru) ПИРИМИДО[4,5-b]ХИНОЛИН-4,5(3H,10H)ДИОНЫ В КАЧЕСТВЕ СУПРЕССОРОВ НОНСЕНС МУТАЦИЙ
JP2004531523A5 (no)
ATE507226T1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
RU2008122401A (ru) Новые n-(фтор-пиразинил)-фенилсульфонамиды в качестве модуляторов хемокинового рецептора ccr4
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
HUP0100102A2 (hu) Fenil-amino-alkilkarbonsav-származékok és fenil-amino-alkilkarbonsav-származékokat tartalmazó gyógyszerészeti készítmények
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
MA27056A1 (fr) Derives d'azolylcarbinols d'aryle (ou d'heteroaryle) pour le traitement de l'incontinence d'urine.
DE60137442D1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
TW200420567A (en) Quinazoline derivatives
MY127036A (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3- trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
ATE344237T1 (de) Hydroxyacetamidobenzolsulfonamidderivate
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
NO20015666L (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
BR112021012834A2 (pt) Derivados de pirimidina para a prevenção e tratamento de infecções bacterianas gram-negativas
MA27091A1 (fr) Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
MXPA04001552A (es) Derivados de n-fenil 2-hidroxi-2-metil-3,3,3-trifluropropanamida sustituida que elevan la actividad de la piruvato deshidrogenasa.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees